JSVRX
Price
$28.86
Change
+$1.13 (+4.08%)
Updated
Aug 22 closing price
Net Assets
1.26B
VISVX
Price
$50.15
Change
+$1.55 (+3.19%)
Updated
Aug 22 closing price
Net Assets
56.44B
Interact to see
Advertisement

JSVRX vs VISVX

Header iconJSVRX vs VISVX Comparison
Open Charts JSVRX vs VISVXBanner chart's image
JPMorgan Small Cap Value R5
Price$28.86
Change+$1.13 (+4.08%)
VolumeN/A
Net Assets1.26B
Vanguard Small Cap Value Index I
Price$50.15
Change+$1.55 (+3.19%)
VolumeN/A
Net Assets56.44B
JSVRX vs VISVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JSVRX vs. VISVX commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSVRX is a Buy and VISVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 56.4B vs. JSVRX (1.26B). VISVX pays higher dividends than JSVRX: VISVX (1.95) vs JSVRX (1.04). JSVRX was incepted earlier than VISVX: JSVRX (19 years) vs VISVX (27 years). JSVRX (0.86) is less costly to investors than VISVX (0.19). JSVRX is a more actively managed with annual turnover of: 61.00 vs. VISVX (16.00). JSVRX has a lower initial minimum investment than VISVX: JSVRX (0) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 9.02 vs. JSVRX (1.97). VISVX return over 5 years is better than : 86.95 vs. JSVRX (42.76).
JSVRXVISVXJSVRX / VISVX
Total Expense Ratio0.840.19442%
Annual Report Gross Expense Ratio0.860.19453%
Fund Existence19 years27 years-
Gain YTD5.2655.77991%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.26B56.4B2%
Annual Yield % from dividends1.041.9553%
Returns for 1 year1.979.0222%
Returns for 3 years6.4528.0523%
Returns for 5 years42.7686.9549%
Returns for 10 years27.69126.8022%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JBAXY14.790.36
+2.52%
Julius Baer Group Ltd.
JGSHF0.64N/A
N/A
JG Summit Holdings, Inc.
GENPF0.01N/A
N/A
GENIX PHARMACEUTICALS CORP.
MIAPF10.02N/A
N/A
MINTO APT REAL ESTATE INVT TR
HKRHF0.09N/A
N/A
HONG KONG RESOURCES HOLDINGS CO LTD